comparemela.com

Latest Breaking News On - துறை ஆஃப் வாஸ்குலர் அறுவை சிகிச்சை இல் சிங்கப்பூர் - Page 1 : comparemela.com

12-Month Data Presented for MedAlliance s Selution SLR in BTK Lesions

12-Month Data Presented for MedAlliance’s Selution SLR in BTK Lesions Created with Sketch. January 28, 2021 MedAlliance announced that 12-month results from the PRESTIGE below-the-knee (BTK) study were presented as a late-breaking trial at LINC 2021, the Leipzig Interventional Course held as a virtual event January 25-29. The study sought to evaluate the safety and performance of the Selution SLR, the company’s sirolimus-eluting balloon for the treatment of long tibial occlusive lesions (TASC C & D) in patients with critical limb ischemia. According to the company, PRESTIGE is a prospective, single-center, physician-initiated clinical study conducted by Associate Professor Tze Tec Chong, MD, and Tjun Yip Tang, MD, who are Senior Consultants in the Department of Vascular Surgery at Singapore General Hospital in Singapore.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.